TWD 530.0
(-1.49%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.49 Billion TWD | 56.38% |
2022 | 4.09 Billion TWD | 32.19% |
2021 | 3.1 Billion TWD | 63.18% |
2020 | 1.89 Billion TWD | 74.81% |
2019 | 1.08 Billion TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.44 Billion TWD | -5.55% |
2024 Q2 | 1.56 Billion TWD | 8.38% |
2023 Q2 | 1.56 Billion TWD | 5.61% |
2023 Q4 | 1.52 Billion TWD | -16.51% |
2023 FY | 6.4 Billion TWD | 56.38% |
2023 Q1 | 1.48 Billion TWD | 7.45% |
2023 Q3 | 1.82 Billion TWD | 16.86% |
2022 Q3 | 1.02 Billion TWD | 0.0% |
2022 FY | 4.09 Billion TWD | 32.19% |
2022 Q4 | 1.37 Billion TWD | 34.29% |
2021 FY | 3.1 Billion TWD | 63.18% |
2020 FY | 1.89 Billion TWD | 74.81% |
2019 FY | 1.08 Billion TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Grape King Bio Ltd | 6.03 Billion TWD | 25.57% |
Standard Chem & Pharm CO., LTD. | 1.46 Billion TWD | -206.658% |
Maywufa Company Ltd. | 854.37 Million TWD | -426.126% |
ScinoPharm Taiwan, Ltd. | 901.49 Million TWD | -398.622% |
Lotus Pharmaceutical Co., Ltd. | 4.48 Billion TWD | -0.317% |
LIWANLI Innovation Co., Ltd. | 54.86 Million TWD | -8092.817% |
YungShin Global Holding Corporation | 2.04 Billion TWD | -119.518% |
PhytoHealth Corporation | 67.64 Million TWD | -6545.286% |
SCI Pharmtech, Inc. | 190.02 Million TWD | -2265.54% |
Formosa Laboratories, Inc. | 1.24 Billion TWD | -260.08% |
Bora Pharmaceuticals Co., LTD. | 1.74 Billion TWD | -158.026% |